Montelukast in Parkinson Disease

Clinical trial NCT06113640 · RECRUITING

Trial details

NCT number: NCT06113640
Sponsor: Mostafa Bahaa
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Parkinson Disease

Start date: 2023-11-05
Primary completion: 2026-11-20
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.